Alembic Pharmaceuticals submits press release

26 Jul 2025 Evaluate

Alembic Pharmaceuticals has submitted press release stating that Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.

The above information is a part of company’s filings submitted to BSE.


Alembic Pharma Share Price

768.55 6.80 (0.89%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×